Login

Actos Lawsuit Update

Written by lisaspitzer on . Posted in Actos Lawsuit Lawyers, Drug Lawsuits, Florida Multidistrict Litigation Lawyers, Maine Multidistrict Litigation Lawyers, Massachusetts Multidistrict Litigation Lawyers, Michigan Multidistrict Litigation Lawyers, Minnesota Multidistrict Litigation Lawyers, Montana Multidistrict Litigation Lawyers, New Hampshire Multidistrict Litigation Lawyers, New Mexico Multidistrict Litigation Lawyers, North Carolina Multidistrict Litigation Lawyers, Rhode Island Multidistrict Litigation Lawyers, South Carolina Multidistrict Litigation Lawyers, Washington DC Multidistrict Litigation Lawyers, Washington Multidistrict Litigation Lawyers, Wisconsin Multidistrict Litigation Lawyers, Wyoming Multidistrict Litigation Lawyers

Actos is a medication taken by Type II  ( adult onset ) diabetics to control their insulin production. Actos lawsuits are being filed for victims of bladder cancer from Actos.

Actos Lawsuit Update

 Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused patients to develop bladder cancer continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to court documents, the proceeding’s next Case Management Conference will be held on Thursday, October 24, 2013, at 10:30 a.m. (In re: Actos Product Liability Litigation, MDL No. 2299)

Actos Lawsuit News

According to court documents Actos litigation involving bladder cancer allegations got underway shortly after the U.S. Food & Drug Administration (FDA) warned in June 2011 that use of the drug for 12 months or more had been associated with an increased risk of the disease. At that time, the FDA ordered Takeda Pharmaceuticals to add new warnings to the Actos label about its potential to cause bladder cancer.
Court filings indicate that more than 2,500 Actos lawsuits are now pending in the Western District of Louisiana, where the first case will go to trial in January. Plaintiffs in Actos lawsuits allege that Takeda Pharmaceuticals and other defendants concealed knowledge that the medication could increase a person’s chances of developing bladder cancer, and failed to provide adequate warnings about that risk to the public and medical community.
On the state level, two Actos claims involving bladder cancer allegations have already gone to trial. Last month, a Maryland State Court jury awarded $1.7 million to the family of a man who died of bladder cancer following long-term use of Actos. However, according to court records, the judge presiding over the trial tossed out the verdict because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)
This past April, a Los Angeles Superior Court jury awarded $6.5 million to a plaintiff who developed bladder cancer following four years of Actos use. However, the plaintiff is currently appealing a decision by the judge overseeing the case to grant Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Long-term users of Actos ( over 2 years ) who have been diagnosed with bladder cancer may be eligible to file an Actos lawsuit against Takeda Pharmaceuticals.

Actos Lawsuit Criteria

1. You must have taken Actos for over two years

2. You must have a confirmed diagnosis of bladder cancer

3. You must have no prior medical history of baldder cancer prior to taking Actos

Tags: , , , , , , , , , , , , , , , , , , , , ,

Switch to Desktop Version